SBC MEDICAL GROUP HOLDINGS I (SBC) Fundamental Analysis & Valuation

NASDAQ:SBC • US73245B1070

Current stock price

4.27 USD
-0.13 (-2.95%)
Last:

This SBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SBC Profitability Analysis

1.1 Basic Checks

  • SBC had positive earnings in the past year.
  • SBC had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SBC reported negative net income in multiple years.
  • In multiple years SBC reported negative operating cash flow during the last 5 years.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

  • With an excellent Return On Assets value of 13.48%, SBC belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 17.47%, SBC belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
  • The Return On Invested Capital of SBC (21.24%) is better than 97.00% of its industry peers.
Industry RankSector Rank
ROA 13.48%
ROE 17.47%
ROIC 21.24%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 24.28%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Operating Margin of SBC (41.70%) is better than 100.00% of its industry peers.
  • SBC's Gross Margin of 74.09% is amongst the best of the industry. SBC outperforms 90.00% of its industry peers.
Industry RankSector Rank
OM 41.7%
PM (TTM) 24.28%
GM 74.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. SBC Health Analysis

2.1 Basic Checks

  • SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for SBC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 6.68 indicates that SBC is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.68, SBC belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.07 indicates that SBC is not too dependend on debt financing.
  • SBC has a better Debt to Equity ratio (0.07) than 79.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 6.68
ROIC/WACC2.42
WACC8.77%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • SBC has a Current Ratio of 5.10. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
  • SBC's Current ratio of 5.10 is amongst the best of the industry. SBC outperforms 93.00% of its industry peers.
  • A Quick Ratio of 5.06 indicates that SBC has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.06, SBC belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 5.06
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SBC Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.92%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.28% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.54% on average over the next years.
EPS Next Y2.03%
EPS Next 2Y10.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.33%
Revenue Next 2Y7.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

6

4. SBC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.71, the valuation of SBC can be described as very reasonable.
  • 94.00% of the companies in the same industry are more expensive than SBC, based on the Price/Earnings ratio.
  • SBC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.51.
  • Based on the Price/Forward Earnings ratio of 8.54, the valuation of SBC can be described as reasonable.
  • 94.00% of the companies in the same industry are more expensive than SBC, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.76. SBC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.71
Fwd PE 8.54
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 95.00% of the companies in the same industry are more expensive than SBC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.49
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SBC does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of SBC may justify a higher PE ratio.
PEG (NY)4.29
PEG (5Y)N/A
EPS Next 2Y10.28%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SBC Dividend Analysis

5.1 Amount

  • SBC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SBC Fundamentals: All Metrics, Ratios and Statistics

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (4/2/2026, 11:10:41 AM)

4.27

-0.13 (-2.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-27
Earnings (Next)05-13
Inst Owners1.3%
Inst Owner ChangeN/A
Ins Owners90.38%
Ins Owner Change0%
Market Cap438.02M
Revenue(TTM)N/A
Net Income(TTM)43.32M
Analysts80
Price Target8.29 (94.15%)
Short Float %2.03%
Short Ratio10.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.66%
Min EPS beat(2)-85.33%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)5.59%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.07%
Min Revenue beat(2)-4.16%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.96%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)-0.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 8.71
Fwd PE 8.54
P/S 2.45
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 1.99
EV/EBITDA 4.49
EPS(TTM)0.49
EY11.48%
EPS(NY)0.5
Fwd EY11.71%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.74
BVpS2.42
TBVpS2.14
PEG (NY)4.29
PEG (5Y)N/A
Graham Number5.16
Profitability
Industry RankSector Rank
ROA 13.48%
ROE 17.47%
ROCE 26.89%
ROIC 21.24%
ROICexc 39.36%
ROICexgc 48.54%
OM 41.7%
PM (TTM) 24.28%
GM 74.09%
FCFM N/A
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA 0.24
Cap/Depr 69.08%
Cap/Sales 1.14%
Interest Coverage 636.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.1
Quick Ratio 5.06
Altman-Z 6.68
F-Score5
WACC8.77%
ROIC/WACC2.42
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.32%
EPS Next Y2.03%
EPS Next 2Y10.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.92%
Revenue Next Year5.33%
Revenue Next 2Y7.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1928.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1816.19%
OCF growth 3YN/A
OCF growth 5YN/A

SBC MEDICAL GROUP HOLDINGS I / SBC Fundamental Analysis FAQ

What is the fundamental rating for SBC stock?

ChartMill assigns a fundamental rating of 5 / 10 to SBC.


Can you provide the valuation status for SBC MEDICAL GROUP HOLDINGS I?

ChartMill assigns a valuation rating of 6 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.


Can you provide the profitability details for SBC MEDICAL GROUP HOLDINGS I?

SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SBC MEDICAL GROUP HOLDINGS I (SBC) stock?

The Price/Earnings (PE) ratio for SBC MEDICAL GROUP HOLDINGS I (SBC) is 8.71 and the Price/Book (PB) ratio is 1.77.


Can you provide the expected EPS growth for SBC stock?

The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to grow by 2.03% in the next year.